These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 26413830)

  • 21. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
    Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production.
    Woolums AR; Siger L; Johnson S; Gallo G; Conlon J
    Vaccine; 2003 Mar; 21(11-12):1158-64. PubMed ID: 12559793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of shedding of bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 after vaccination of calves with a multivalent modified-live virus vaccine.
    Kleiboeker SB; Lee SM; Jones CA; Estes DM
    J Am Vet Med Assoc; 2003 May; 222(10):1399-403. PubMed ID: 12762386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
    Platt R; Burdett W; Roth JA
    Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
    Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of BHV-1 antibody titer in a cattle herd against different BHV-1 strains.
    Lee M; Reed A; Estill C; Izume S; Dong J; Jin L
    Vet Microbiol; 2015 Sep; 179(3-4):228-32. PubMed ID: 26123370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-mediated and humoral immune responses to bovine herpesvirus type 1 and bovine viral diarrhea virus in calves following administration of a killed-virus vaccine and bovine herpesvirus type 1 challenge.
    Van Anne TR; Rinehart CL; Buterbaugh RE; Bauer MJ; Young AJ; Blaha ML; Klein AL; Chase CCL
    Am J Vet Res; 2018 Nov; 79(11):1166-1178. PubMed ID: 30372148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of the effectiveness of a needle-free injection device compared with a needle and syringe used to vaccinate calves against bovine viral diarrhea and infectious bovine rhinotracheitis viruses.
    Rey MR; Undi M; Rodriguez-Lecompte JC; Joseph T; Morrison J; Yitbarek A; Wittenberg K; Tremblay R; Crow GH; Ominski KH
    Vet J; 2013 Oct; 198(1):235-8. PubMed ID: 24011475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the efficacy of a modified-live combination vaccine against bovine viral diarrhea virus types 1 and 2 challenge exposures in a one-year duration-of-immunity fetal protection study.
    Ficken MD; Ellsworth MA; Tucker CM
    Vet Ther; 2006; 7(3):283-94. PubMed ID: 17039451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
    Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
    J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing antibody responses in preconditioned calves following vaccination for respiratory viruses.
    Grooms DL; Coe P
    Vet Ther; 2002; 3(2):119-27. PubMed ID: 19750742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of bovine respiratory disease or vaccination with serologic response in dairy heifer calves up to three months of age.
    Windeyer MC; Leslie KE; Godden SM; Hodgins DC; Lissemore KD; LeBlanc SJ
    Am J Vet Res; 2015 Mar; 76(3):239-45. PubMed ID: 25710760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
    Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1.
    DesCôteaux L; Cécyre D; Elsener J; Beauchamp G
    Can Vet J; 2003 Oct; 44(10):816-21. PubMed ID: 14601677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Occurrence of a Commercial N
    Wernike K; Michelitsch A; Aebischer A; Schaarschmidt U; Konrath A; Nieper H; Sehl J; Teifke JP; Beer M
    Viruses; 2018 May; 10(5):. PubMed ID: 29783722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of neonatal vaccination for bovine respiratory disease in the face of a dual challenge with bovine viral diarrhea virus and Mannheimia hemolytica.
    Perkins-Oines S; Dias N; Krafsur G; Abdelsalam K; Perry G; Ensley D; Jones C; Chase CCL
    Vaccine; 2023 May; 41(19):3080-3091. PubMed ID: 37045678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Kinetics and persistence of neutralizing antibodies against bovine viral diarrhea virus-1 and -2 and border disease virus after two step vaccination of cattle].
    Oguzoglu TC; Frey HR; Eicken K; Grummer B; Liess B; Moennig V
    Dtsch Tierarztl Wochenschr; 2003 Jan; 110(1):14-7. PubMed ID: 12596665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
    Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.